Latest drug resistance News

WHO recommends long-acting cabotegravir for HIV prevention
UNSW researchers named as 2022 Eureka Prize finalists
Hormone-blocking breakthrough helps combat skin cancer recurrence
Hormone-blocking breakthrough helps combat skin cancer recurrence
Lack of innovation set to undermine antibiotic performance and health gains
Clinical trial to test potential new combination therapy for aggressive breast cancer
Queen’s Birthday honours for rare cancers researcher and clinician
People’s choice voting opens in research awards
Updated WHO recommendations for malaria chemoprevention among children and pregnant women
New weapon against malaria’s drug resistance
Prime Minister’s Science Prizes showcase New Zealanders ‘inspiring tomorrow’
TB laboratory manuals issued to support implementation of WHO-recommended diagnostics
Major discovery provides new hope for blood cancer patients
Scientists closer to outsmarting malaria parasites
WHO issues rapid communication on updated guidance for treatment of drug-resistant tuberculosis
Three pillars of malaria elimination
Over 1 million African children protected by first malaria vaccine
Ludwig Cancer Research scientists to present advances in cancer immunotherapy, metastasis
ACRF grant boosts cancer research capability
New malaria treatments essential as drug resistance grows
IWD 2022: Malaria and journey from control to elimination
World leaders and experts call for action to protect environment from antimicrobial pollution
Childhood cancer research pioneers backed by Four Diamonds and THON
$2.5M grant awarded to flip switch on lung cancer drug resistance
Development of New Gastric Cancer Model: Identification of Gastric Cancer Stem Cells
It’s not all in their DNA: cancer cells with same genome can behave differently
Unsung gene is key to how antibodies develop: University of Toronto study
WHO releases HIV drug resistance report 2021
Targeting Stem Cell Signaling Could Halt Liver Cancer Progression Elucidating novel therapeutic target
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
Australia to lead in antimicrobial resistance